Table 4.
Cardiovascular Risk/Disease | All Sample | Low-Performance Group | Normative Performance Group | p Value |
Systolic blood pressure, mmHg | 130.8 ± 0.8 | 133.5 ± 2.0 | 130.8 ± 0.8 | .05 |
Diastolic blood pressure, mmHg | 70.2 ± 0.4 | 68.8 ± 1.0 | 70.5 ± 0.4 | .08 |
Pulse pressure, mmHg | 60.4 ± 0.7 | 64.7 ± 1.7 | 59.0 ± 0.7 | .001 |
Total cholesterol, mg/dL | 186.5 ± 1.8 | 186.0 ± 4.7 | 186.7 ± 1.9 | .88 |
Low-density lipoprotein, mg/dL | 108.4 ± 1.5 | 112.2 ± 4.1 | 108.1 ± 1.6 | .31 |
Hypertension, % | 78 | 93 | 75 | .0001 |
Uncontrolled hypertension, % | 26 | 34 | 23 | .0004 |
Antihypertensives, % | 68 | 82 | 64 | .0008 |
Stroke, % | 10 | 17 | 8 | .005 |
Heart disease, % | 27 | 29 | 26 | .56 |
Atrial fibrillation, % | 24 | 22 | 24 | .62 |
Congestive heart failure, % | 5 | 10 | 4 | .006 |
Diabetes mellitus, % | 17 | 30 | 14 | .0002 |
Framingham score | 10.9 ± 0.1 | 12.0 ± 0.3 | 10.6 ± 0.2 | .0001 |